- Home
- CTV vs ESPR Comparison
CTV vs ESPR Comparison
Compare CTV & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTV
- ESPR
- Stock Information
- Founded
- CTV 2007
- ESPR 2008
- Country
- CTV United States
- ESPR United States
- Employees
- CTV N/A
- ESPR N/A
- Industry
- CTV Advertising
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- CTV Consumer Discretionary
- ESPR Health Care
- Exchange
- CTV Nasdaq
- ESPR Nasdaq
- Market Cap
- CTV 279.6M
- ESPR 319.2M
- IPO Year
- CTV N/A
- ESPR 2013
- Fundamental
- Price
- CTV $1.67
- ESPR $2.12
- Analyst Decision
- CTV Buy
- ESPR Buy
- Analyst Count
- CTV 3
- ESPR 4
- Target Price
- CTV $2.83
- ESPR $8.17
- AVG Volume (30 Days)
- CTV 273.9K
- ESPR 4.8M
- Earning Date
- CTV 11-12-2024
- ESPR 11-07-2024
- Dividend Yield
- CTV N/A
- ESPR N/A
- EPS Growth
- CTV N/A
- ESPR N/A
- EPS
- CTV N/A
- ESPR N/A
- Revenue
- CTV $151,557,000.00
- ESPR $295,451,000.00
- Revenue This Year
- CTV $15.63
- ESPR $198.22
- Revenue Next Year
- CTV $12.98
- ESPR $25.83
- P/E Ratio
- CTV N/A
- ESPR N/A
- Revenue Growth
- CTV 12.30
- ESPR 187.12
- 52 Week Low
- CTV $1.22
- ESPR $1.08
- 52 Week High
- CTV $2.58
- ESPR $3.40
- Technical
- Relative Strength Index (RSI)
- CTV 35.24
- ESPR 50.12
- Support Level
- CTV $1.58
- ESPR $1.87
- Resistance Level
- CTV $1.85
- ESPR $2.60
- Average True Range (ATR)
- CTV 0.13
- ESPR 0.17
- MACD
- CTV -0.03
- ESPR -0.01
- Stochastic Oscillator
- CTV 15.03
- ESPR 34.25
About CTV Innovid Corp.
Innovid Corp is a software platform that provides ad serving, measurement and optimization creative services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV and desktop TV environments to advertisers, publishers and media agencies. It is engaged in ad serving, measurement and creative services. It operates in U.S., Canada, EMEA, APAC and LATAM, out of which it derives maximum revenue from U.S.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.